The deal range was $23.50-$24.50. JPMorgan, Goldman Sachs, Jefferies and RBC Capital acted as joint book running managers for the offering.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on IDYA:
- Ideaya Biosciences $125M Spot Secondary; price range $23.50-$24.50
- Ideaya Biosciences files to sell $125M in common stock and pre-funded warrants
- Ideaya Biosciences price target raised to $36 from $32 at RBC Capital
- Ideaya Biosciences price target raised to $35 from $32 at JPMorgan
- Ideaya Biosciences announces expansion of darovasertib, crizotinib combination